A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate plus Prednisonewith or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer

Project: Research project

Project Details

Description

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer
StatusActive
Effective start/end date9/1/188/30/22

Funding

  • Eli Lilly and Company

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.